• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 418402 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416564264 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416564264 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Stock Investors Bid Up Shares of Masimo, Up 1.4%

Published on Wed, 01/09/2013 - 11:27
By Adrienne Chilton

Up 1.4% to $19.93, Masimo (NASDAQ:MASI), is one of today's notable movers. The Dow Jones Industrial Average is now trading 0.5% higher to 13,399 and the S&P is trading 0.4% higher to 1,462.

Masimo share prices have moved between a 52-week high of $35.15 and a 52-week low of $17.62 and are now trading 13% above that low price at $19.93 per share. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.6% while the 200-day MA has slid 0.2%.

Masimo (NASDAQ:MASI) has potential upside of 30.0% based on a current price of $19.93 and analysts' consensus price target of $25.92. Masimo shares should first meet resistance at the 50-day moving average (MA) of $20.94 and find additional resistance at the 200-day MA of $21.77.

Masimo Corporation designs, develops and licenses medical signal processing and sensor technology for the noninvasive monitoring of physiological parameters. The Company's first products are designed to improve the effectiveness of pulse oximetry by overcoming the inability of current monitors to precisely measure the levels of arterial blood oxygen saturation and low arterial blood flow.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Shares of DENTSPLY International Rise to...

Shares of DENTSPLY International (NASDAQ:XRAY) traded at a new 52-week high today of $5 ...

Shares of Williams-Sonoma Rise Above Pre...

Williams-Sonoma (NYSE:WSM) traded today at a new 52-week high of $76.55. So far today ...

Whirlpool Looks to Continue to Trade Abo...

Whirlpool (NYSE:WHR) traded at a new 52-week high today of $182.34. So far today appro ...

Waters: The Winning Streak Continues (WA...

Waters (NYSE:WAT) traded at a new 52-week high today of $116.68. Approximately 800,000 ...

Shares of Validus Holdings Have Risen Ab...

Shares of Validus Holdings (NYSE:VR) traded at a new 52-week high today of $41.18. Thi ...

Shares of VF Corp Rise Above Previous 52...

Shares of VF Corp (NYSE:VFC) traded today at $73.31, breaking its 52-week high. This n ...

Shares of Vale Fall Below Previous 52-We...

Shares of Vale (NASDAQ:VALE) traded today at $8.40, breaking its 52-week low. Approxim ...

Textron: 52-Week High Recently Eclipsed ...

Shares of Textron (NYSE:TXT) traded today at $43.24, breaking its 52-week high. So far ...